CoreWeave vs Vercel: employee equity compared
Secondary market prices, valuation trajectory, equity structure, and liquidity outlook for employees choosing between CoreWeave and Vercel.
CoreWeave
Specialised GPU cloud provider purpose-built for AI/ML training and inference — 45,000+ NVIDIA H100s available on-demand.
IPO plausible 2027–2029 if growth trajectory holds. Liquidity may come via tender offer or strategic acquisition before listing.
Sticky enterprise ARR; RSU (no exercise cost); IPO imminent when ARR > $1B
Vercel
Frontend cloud and deployment platform — the creator of Next.js (used by TikTok, Twitch, Hulu) and the host for 6M+ frontend deployments.
IPO possible 2027–2029 once ARR milestones are hit. Strategic M&A also plausible in consolidating sector.
Sticky enterprise ARR; ISO/NSO options; IPO imminent when ARR > $1B
Key differences for employees
Equity structure
CoreWeave grants RSU — no exercise cost. Your equity vests and converts to cash or shares automatically at a liquidity event. Vercel grants ISO/NSO with strike prices from $12–$20.
Secondary market premium
The secondary market is pricing CoreWeave at a +3% premium over its last primary round ($19B → $19.6B). Vercel trades at +2% over its last round ($3.3B → $3.3B). A higher secondary premium signals stronger investor demand and potentially better near-term liquidity for employees looking to sell.
Revenue and growth
CoreWeave runs at $2B ARR, growing +150% YoY (very fast). Vercel runs at $0.1B ARR, growing +80% YoY (fast). Revenue growth rate matters for equity because it drives the peer-multiple valuation — the method most correlated with exit multiples.
Liquidity timeline
CoreWeave: IPO plausible 2027–2029 if growth trajectory holds. Liquidity may come via tender offer or strategic acquisition before listing.
Vercel: IPO possible 2027–2029 once ARR milestones are hit. Strategic M&A also plausible in consolidating sector.
Calculate your specific grant
Enter your actual shares, equity type, and strike price. PrivatePulse calculates your personal equity value at both companies using 4 independent methods.